RecruitingNCT06336239

PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study


Sponsor

Beijing Anzhen Hospital

Enrollment

3,000 participants

Start Date

Dec 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The association between Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) is well established. Traditional risk factors for CVD and CKD are similar, with type 2 diabetes mellitus (T2DM) being the most prevalent risk factor. However, CKD is underdiagnosed and undertreated in patients with CVD. Further understanding of the combination of CKD in CVD patients is important to formulate prevention and treatment strategies for CVD patients and high-risk groups, reduce adverse events in CVD patients, and prevent progression of CKD to End Stage Renal Disease (ESRD).


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18 years old;
  • Diagnosed T2DM combined with ≥1 CVD (hypertension, coronary heart disease, atrial fibrillation, heart failure);
  • During the data collection period, they went to the outpatient clinic of the cardiology department of the research center, or received treatment in the cardiology department;
  • Ability to self-sign informed consent (electronic /paper).

Exclusion Criteria7

  • Pregnant or lactating women;
  • Dialysis patients;
  • Other diseases that lead to elevated albuminuria, such as severe infection, confirmed primary glomerular disease, etc.;
  • Malignant tumors being treated (surgery, chemotherapy, radiotherapy or targeted therapy);
  • Cachexia (CSS score ≥ 5 points);
  • Severe liver disease (Child- Pugh grade C) ;
  • Participated in an interventional clinical trial in the past three months.

Locations(27)

Beijing Sixth Hospital

Beijing, Beijing Municipality, China

Fangshan District First Hospital

Beijing, Beijing Municipality, China

Peking University Third Hospital

Beijing, Beijing Municipality, China

Chinese PLA Army Characteristic Medical Center

Chongqing, Chongqing Municipality, China

Haidong City Second People's Hospital

Haidong, Gansu, China

The First Affiliated Hospital of Sun Yat-sen University

Guangzhou, Guangdong, China

First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Ruyang County People's Hospita

Luoyang, Henan, China

Luoyang Sixth People's Hospita

Luoyang, Henan, China

Yongcheng People's Hospital

Yongcheng, Henan, China

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

Zhangjiagang Sixth People's Hospital

Zhangjiagang, Jiangsu, China

Shenyang Ninth People's Hospital

Shenyang, Liaoning, China

Shenyang Tenth People's Hospital

Shenyang, Liaoning, China

Jining First People's Hospital

Jining, Shandong, China

Tai'an First People's Hospital

Tai’an, Shandong, China

Weihai Central Hospital

Weihai, Shandong, China

Jing'an District Central Hospital of Shanghai

Shanghai, Shanghai Municipality, China

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, China

Zhongshan Hospital Fudan University Qingpu Branch

Shanghai, Shanghai Municipality, China

Qinyuan County People's Hospital

Changzhi, Shanxi, China

Shanxi Bethune Hospital

Taiyuan, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University

XI Ail, Shanxi, China

The Fifth People's Hospital of Sichuan Province

Chengdu, Sichuan, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

Taizhou Central Hospital

Taizhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06336239


Related Trials